Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study
Heppner, D Gray, Kemp, Tracy L, Martin, Brian K, Ramsey, William J, Nichols, Richard, Dasen, Emily J, Link, Charles J, Das, Rituparna, Xu, Zhi Jin, Sheldon, Eric A, Nowak, Teresa A, Monath, Thomas P,Langue:
english
Journal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(17)30313-4
Date:
June, 2017
Fichier:
PDF, 659 KB
english, 2017
File converter
Plus de résultats de recherche
More benefits 
